Narrative updates are currently in beta.

Back to narrative

Update shared on07 Aug 2025

Fair value Increased 5.09%
AnalystConsensusTarget's Fair Value
€5.16
10.2% undervalued intrinsic discount
15 Aug
€4.63
Loading
1Y
131.5%
7D
6.8%

Clariane’s fair value has been revised upward as improving net profit margin outweighed the impact of a higher discount rate, resulting in the consensus price target rising from €4.91 to €5.16.


What's in the News


  • Clariane SE expects organic sales growth of around 5% for 2025, supported by strong momentum in France and Germany, with ramp-up contributions in the Netherlands and Spain.
  • The Board held a meeting to review the condensed interim consolidated financial statements for the first half of 2025.

Valuation Changes


Summary of Valuation Changes for Clariane

  • The Consensus Analyst Price Target has risen from €4.91 to €5.16.
  • The Net Profit Margin for Clariane has significantly risen from 2.77% to 3.18%.
  • The Discount Rate for Clariane has significantly risen from 10.69% to 11.78%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.